Document is current
Any future updates will be listed below
-
Authors
Carrero, Juan J. https://orcid.org/0000-0003-4763-2024
St-Jules, David E.
Biruete, Annabel https://orcid.org/0000-0003-2549-0539
Cuppari, Lilian https://orcid.org/0000-0002-5927-9179
Piccoli, Giorgina B.
Picard, Kelly
Hansen, Nikita M. https://orcid.org/0000-0002-6009-5617
Sabatino, Alice
Winkelman, Dillon
Avesani, Carla M. https://orcid.org/0000-0002-4458-8358
- License Information
-
More Information
Article History
Accepted: 3 November 2025
First Online: 5 January 2026
Competing interests
: J.J.C. participated in the making of the 2024 KDIGO, 2020 KDOQI and 2021 ESPEN clinical guidelines, which contain statements regarding the dietary management of people with chronic and acute kidney disease. He also acknowledges receiving within the last 2 years speaker fees or advisory board fees from Abbott, Fresenius Kabi and Laboratorios Columbia, which commercialize nutritional products for people with kidney disease. A.B. is part of the NextGen Scientists Cohort of the National Dairy Council, and has received honoraria from Ardelyx, Fresenius Medical Care North America, and Dialysis Clinics Inc. L.C. participated in the making of the 2020 KDOQI CKD nutrition guideline. She also acknowledges receiving AstraZeneca, Fresenius Kabi and Abbott Laboratories speaker or advisory board fees. G.B.P. acknowledges receiving within the last 2 years speaker fees and advisory board fees from Fresenius Kabi and travel support by Dr Shar. A.S. participated in the making of the 2021 ESPEN clinical guideline which contains statements regarding the dietary management of people with acute kidney injury. She also acknowledges receiving within the last 2 years speaker fees or advisory board fees from Fresenius Kabi. C.M.A. received speaker honoraria from AstraZeneca, Fresenius Medical Care, Abbott and Baxter Healthcare and received honoraria as advisory board member from Fresenius Kabi. The other authors declare no competing interests.
